| Peer-Reviewed

Effect of Smoking on Serum Vitamin D Levels and the Influence on COPD Symptoms Using NHANES 2007 – 2014 Datasets Among Women of Different Ethnic Backgrounds

Received: 16 December 2020    Accepted: 23 December 2020    Published: 13 April 2023
Views:       Downloads:
Abstract

Smoking is one of the major causes of chronic obstructive pulmonary disease (COPD). The number of women who smoke is increasing and they are at enhanced risk of developing fatal COPD. Symptoms of COPD include frequent coughing, wheezing, whistling, excess phlegm and shortness of breath. According to National Health Interview Survey (NHIS) data during 1999 to 2011, the prevalence of COPD among non-Hispanic whites was generally higher contrasted with non-Hispanic blacks and Hispanics. Among women the annual age-adjusted prevalence was higher than in men, especially among young women. It is likely that nutritional status of COPD patients may impact the outcome of the disease. Deficient levels of vitamin D is common among COPD patients. The goal of this study is to further investigate a potential correlation between smoking and serum vitamin D levels as it influences COPD. The National Health and Nutrition Examination Survey (NHANES) 2007-2014 datasets were utilized for this study. A 10 ng/mL decrease in vitamin D3 level was associated with an increased number of wheezing and whistling attacks (relative risk (RR) 1.33 (95% CI (1.03, 1.07), P=0.02). There was no evidence of an association between vitamin D2 with the number of wheezing and whistling attacks. Although there was no evidence of an association between vitamin D3 (either lower or higher levels) with bringing up phlegm and coughing, there was marginal evidence P<0.1 of an association between vitamin D2 with bringing up phlegm and coughing. Conclusion: This data confirmed the previous conclusion from an NHANES 2001-2006 investigation that smoking may still influence vitamin D3 levels among women. Further research is necessary to better understand whether vitamin D3 has a positive impact on respiratory health in women because they are more likely to be burdened by the symptoms of COPD.

Published in International Journal of Nutrition and Food Sciences (Volume 12, Issue 2)
DOI 10.11648/j.ijnfs.20231202.12
Page(s) 46-55
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

NHANES, Cotinine, Vitamin D, Women, Smoking, Chronic Obstructive Pulmonary Disease (COPD)

References
[1] World Health Organization (WHO) - Tobacco Free Initiative (TFI). (2020, June 17). WHA33.35 WHO’s program on smoking and health. Retrieved from https://www.who.int/tobacco/framework/wha_eb/wha33_35/en/
[2] World Health Organization (WHO) - Tobacco Free Initiative (TFI). (2020, June 17). WHA31.56 Health hazards of smoking. Retrieved from https://www.who.int/tobacco/framework/wha_eb/wha31_56/en/
[3] World Health Organization (WHO) - Tobacco Free Initiative (TFI). (2020, June 17). WHA23.32 Health Consequences of Smoking. Retrieved from https://www.who.int/tobacco/framework/wha_eb/wha23_32/en/
[4] World Health Organization (WHO). (2020, June 17). Tobacco. Retrieved from https://www.who.int/health-topics/tobacco#tab=tab_1
[5] World Health Organization (WHO). (2020, May 27). Tobacco. Retrieved from https://www.who.int/news-room/fact-sheets/detail/tobacco
[6] An, R. (2015). Health care expenses in relation to obesity and smoking among U.S. adults by gender, race/ethnicity, and age group: 1998–2011. Public Health, 129 (1), 29–36. doi: 10.1016/j.puhe.2014.11.003.
[7] Centers for Disease Control and Prevention (CDC). (2017, April 7). National Biomonitoring Program - Cotinine Factsheet. Retrieved from https://www.cdc.gov/biomonitoring/Cotinine_FactSheet.html
[8] Centers for Disease Control and Prevention (CDC). (2017, April 7). National Biomonitoring Program - Biomonitoring Summary: Cotinine. Retrieved from https://www.cdc.gov/biomonitoring/Cotinine_BiomonitoringSummary.html
[9] World Health Organization (WHO). (2010, May 30). 10 Facts on gender and tobacco - Gender equality is good for health. Retrieved from https://www.who.int/gender/documents/10facts_gender_tobacco_en.pdf
[10] Ram, J. B. (2020). Nicotine metabolite ratios in serum and urine among US adults: variations across smoking status, gender and race/ethnicity. Biomarkers, 25 (1), 27–33. doi: 10.1080/1354750X.2019.1688866.
[11] World Health Organization (WHO) - Tobacco Free Initiative (TFI). (2010, May 31). World No Tobacco Day 2010 - Theme: Gender and tobacco with an emphasis on marketing to women. Retrieved from https://www.who.int/tobacco/wntd/2010/announcement/en/
[12] World Health Organization (WHO). (2008). WHO Report on the Global Tobacco Epidemic - The MPOWER package. Geneva, Switzerland: WHO.
[13] Centers for Disease Control and Prevention (CDC). (2018, June 6). Chronic Obstructive Pulmonary Disease (COPD) - What is COPD? Retrieved from https://www.cdc.gov/copd/index.html
[14] Kochanek, K. D., Xu, J., Murphy, S. L., Miniño, A. M., & Kung, H.-C. (2011). National Vital Statistics Reports. Deaths: Preliminary Data for 2009. Division of Vital Statistics, 59 (4), 1–51. Retrieved from https://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_04.pdf?fbclid=IwAR3SFEndKVF7l-RpvOgSHjudzT4XmLQu8wyQbknhdK1JdIIQ3n62REZcrcc
[15] Centers for Disease Control and Prevention (CDC). Smoking attributable mortality, years of potential life lost, and productivity losses—United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008; 57 (45): 1226-1228.
[16] Centers for Disease Control and Prevention (CDC). (2019, June 20). Morbidity and Mortality Weekly Report (MMWR) - Chronic Obstructive Pulmonary Disease and Smoking Status — United States, 2017. Retrieved from https://www.cdc.gov/mmwr/volumes/68/wr/mm6824a1.htm
[17] Centers for Disease Control and Prevention (CDC). (2020, June 9). Chronic Obstructive Pulmonary Disease (COPD) - COPD: Symptoms, Diagnosis, and Treatment. Retrieved from https://www.cdc.gov/copd/features/copd-symptoms-diagnosis-treatment.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Ffeatures%2Fcopd-awareness-month%2Findex.html
[18] Ford, E. S., Croft, J. B., Mannino, D. M., Wheaton, A. G., Zhang, X., & Giles, W. H. (2013). COPD Surveillance-United States, 1999-2011. Chest, 144 (1), 284–305. doi: 10.1378/chest.13-0809.
[19] Stelmach, R., Arrabal Fernandes, F. L., Carvalho-Pinto, R. M., Athanazio, R. A., Rached, S. Z., Prado, G. F., & Cukier, A. (2015). Comparison between objective measures of smoking and self-reported smoking status in patients with asthma or COPD: are our patients telling us the truth? The Brazilian Journal of Pulmonology and International Databases, 41 (2), 124–132. doi: 10.1590/S1806-37132015000004526.
[20] Centers for Disease Control and Prevention (CDC) (2012). Chronic obstructive pulmonary disease among adults--United States, 2011. MMWR. Morbidity and mortality weekly report, 61 (46), 938–943.
[21] Eisner, M. D., Balmes, J., Yelin, E. H., Katz, P. P., Hammond, K., Benowitz, N., & Blanc, P. D. (2006). Directly measured secondhand smoke exposure and COPD health outcomes. BMC Pulmonary Medicine, 6 (12), 1–11. doi: 10.1186/1471-2466.
[22] Cornell, K., Alam, M., Lyden, E., Wood, L., LeVan, T. D., Nordgren, T. M., … Hanson, C. (2019). Saturated Fat Intake Is Associated with Lung Function in Individuals with Airflow Obstruction: Results from NHANES 2007–2012. Nutrients, 11 (2), 317–329. doi: 10.3390/nu11020317.
[23] Cheng, T.-Y. D., LaCroix, A. Z., Beresford, S. A., Goodman, G. E., Thornquist, M. D., Zheng, Y., … Neuhouser, M. L. (2013). Vitamin D intake and lung cancer risk in the Women’s Health Initiative. The American Journal of Clinical Nutrition, 98 (4), 1002–1011. doi: 10.3945/ajcn.112.055905.
[24] Rutten, E., Franssen, F. M., Vanfleteren, L., Spruit, M. A., Hofstra, T., Ubachs, T., … Reynaert, N. (2015). SUN-LB006: Skin Autofluorescence is a Determinant for Vitamin D in Women with COPD. Clinical Nutrition, 34 (1), S237. doi: 10.1016/S0261-5614(15)30727-5.
[25] Morabia, A., Bernstein, M. S., & Antonini, S. (2000). Smoking, dietary calcium and vitamin D deficiency in women: A population-based study. European Journal of Clinical Nutrition, 54 (9), 684-9. doi: 10.1038/sj.ejcn.1601074.
[26] Dixon, K. M., & Mason, R. S. (2009). Molecules in focus Vitamin D. The International Journal of Biochemistry & Cell Biology, 41, 982–985. doi: 10.1016/j.biocel.2008.06.016.
[27] Holick, M. F. (2004). Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition, 79, 362–371. doi: 10.1093/ajcn/79.3.362.
[28] Holick, M. F., & Chen, T. (2008). Vitamin D deficiency: a worldwide problem with health consequences. American Journal of Clinical Nutrition, 87 (4), 1080S–1086S. doi: 10.1093/ajcn/87.4.1080S.
[29] Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N et al.,. Vitamin D and Chronic Diseases. Aging and disease. (2017); 8 (3): 346-353. doi: 10.14336/AD.2016.1021.
[30] Brot, C., Jorgensen, N. R., & Sorensen, O. H. (1999). The influence of smoking on vitamin D status and calcium metabolism. European Journal of Clinical Nutrition, 53, 920–926. doi: 0.1038/sj.ejcn.1600870.
[31] Cutillas-Marco, E., Fuertes-Prosper, Amparo, Grant, W. B., & Morales-Suárez-Varela, M. (2012). Vitamin D deficiency in South Europe: effect of smoking and aging. Photodermatology Photoimmunology and Photomedicine, 28 (3), 159–161. doi: 10.1111/j.1600-0781.2012.00649.x.
[32] Black, P. N., & Scragg, R. (2005). Relationship Between Serum 25-Hydroxyvitamin D and Pulmonary Function in the Third National Health and Nutrition Examination Survey. American College of Chest Physicians, 128 (6), 3792–3798. doi: 10.1378/chest.128.6.3792.
[33] Hendryx, M., & Luo, J. (2015). A test of vitamin D benefits on respiratory health mediated through inflammatory markers. Chronic Respiratory Disease, 12 (1), 24–30. doi: 10.1177/1479972314556086.
[34] Janssens, W., Bouillon, R., Claes, B., Carremans, C., Lehouck, A., Buysschaert, I., … Lambrechts, D. (2009). Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax, 65 (3), 205–220. doi: 10.1136/thx.2009.120659.
[35] Mekov, E., Slavova, Y., Tsakova, A., Genova, M., Kostadinov, D., Minchev, D., … Tafradjiiska, M. (2015). Vitamin D Deficiency and Insufficiency in Hospitalized COPD Patients. PLOS One, 10 (6), 1–14. doi: 10.1371/journal.pone.0129080.
[36] Mercy Medical Center - A ministry of the Sisters of Charity Health System. (2018, July 1). 42% Percent of Americans Are Vitamin D Deficient. Are You Among Them? Retrieved from https://www.cantonmercy.org/healthchat/42-percent-of-americans-are-vitaminD-deficient/#:~:text=Unfortunately%2C%20about%2042%25%20of%20the,take%20prescription%20medication%20long%20term
[37] Manavi K, Alston-Mills B, Thompson M, Allen J. Effect of serum cotinine on vitamin D serum concentrations among American females with different ethnic backgrounds. Anticancer Res. 2015; 35 (2): 1211-1218.
[38] Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Ross, A. C., Taylor, C. L., Yaktine, A. L., & Del Valle, H. B. (Eds.). (2011). Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press (US).
[39] Biancuzzo, R. M., Clarke, N., Reitz, R. E., Travison, T. G., & Holick, M. F. (2013). Serum Concentrations of 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 in Response to Vitamin D2 and Vitamin D3 Supplementation. The Journal of Clinical Endocrinology & Metabolism, 98 (3), 973–979. doi: 10.1210/jc.2012-2114.
[40] Tripkovic, L., Wilson, L. R., & Lanham-New, S. A. (2017). Vitamin D2 vs. vitamin D3: They are not one and the same. British Nutrition Foundation - Nutrition Bulletin, 42, 331–337. doi: 10.1111/nbu.12293.
[41] Caraballo, R. S., Sharapova, S. R., & Asman, K. J. (2016). Does a Race-Gender-Age Crossover Effect Exist in Current Cigarette Smoking Between Non- Hispanic Blacks and Non-Hispanic Whites? United States, 2001–2013. Nicotine & Tobacco Research, 18 (1), S41–S48. doi: 10.1093/ntr/ntv150.
[42] Pérez-Stable, E. J., Herrera, B., Jacob III, P., & Benowitz, N. L. (1998). Nicotine Metabolism and Intake in Black and White Smokers. The Journal of the American Medical Association, 280 (2), 152–156. doi: 10.1001/jama.280.2.152.
[43] Jones, P., Lucock, M., Veysey, M., & Beckett, E. (2018). The vitamin D-folate hypothesis as an evolutionary model for skin pigmentation: An update and integration of current ideas. Nutrients, 10 (5), 554. doi: http://dx.doi.org.prox.lib.ncsu.edu/10.3390/nu10050554
[44] Schols AM, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 1991; 54: 983–7.
[45] Rawal, G., & Yadav, S. (2015). Nutrition in chronic obstructive pulmonary disease: A review. Journal of translational internal medicine, 3 (4), 151–154. https://doi.org/10.1515/jtim-2015-0021
[46] Persson, L. J. P., Aanerud, M., Hiemstra, P. S., Hardie, J. A., Bakke, P. S., & Eagan, T. M. L. (2012). Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D. PLoS One, 7 (6), e38934–. doi: 10.1371/journal.pone.0038934.
[47] Hendryx, M., & Luo, J. (2015). A test of vitamin D benefits on respiratory health mediated through inflammatory markers. Chronic Respiratory Disease, 24–30. https://doi.org/10.1177/1479972314556086
[48] Han, Y. Y., Forno, E., & Celedón, J. C. (2017). Vitamin D Insufficiency and Asthma in a US Nationwide Study. The journal of allergy and clinical immunology. In practice, 5 (3), 790–796.e1. https://doi.org/10.1016/j.jaip.2016.10.013
[49] DeMeo, D. L., Ramagopalan, S., Kavati, A., Vegesna, A., Han, M. K., Yadao, A., Wilcox, T. K., Make, B. J., & COPD Gene Investigators (2018). Women manifest more severe COPD symptoms across the life course. International journal of chronic obstructive pulmonary disease, 13, 3021–3029. https://doi.org/10.2147/COPD.S160270
[50] Zhu B, Zhu B, Xiao C, Zheng Z. Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015; 10 (1): 1907-1916. https://doi.org/10.2147/COPD.S89763
[51] Zhu M, Wang T, Wang C, Ji Y. The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016; 11 (1): 2597-2607. https://doi.org/10.2147/COPD.S101382
[52] Kentson M, Leanderson P, Jacobson P, Persson HL. The influence of disease severity and lifestyle factors on the peak annual 25(OH)D value of COPD patients. Int J Chron Obstruct Pulmon Dis. 2018; 13: 1389-1398. https://doi.org/10.2147/COPD.S156121
Cite This Article
  • APA Style

    Kiano Manavi, Brenda Alston-Mills, Marvin Thompson, Ethan Davis, Jonathan Allen. (2023). Effect of Smoking on Serum Vitamin D Levels and the Influence on COPD Symptoms Using NHANES 2007 – 2014 Datasets Among Women of Different Ethnic Backgrounds. International Journal of Nutrition and Food Sciences, 12(2), 46-55. https://doi.org/10.11648/j.ijnfs.20231202.12

    Copy | Download

    ACS Style

    Kiano Manavi; Brenda Alston-Mills; Marvin Thompson; Ethan Davis; Jonathan Allen. Effect of Smoking on Serum Vitamin D Levels and the Influence on COPD Symptoms Using NHANES 2007 – 2014 Datasets Among Women of Different Ethnic Backgrounds. Int. J. Nutr. Food Sci. 2023, 12(2), 46-55. doi: 10.11648/j.ijnfs.20231202.12

    Copy | Download

    AMA Style

    Kiano Manavi, Brenda Alston-Mills, Marvin Thompson, Ethan Davis, Jonathan Allen. Effect of Smoking on Serum Vitamin D Levels and the Influence on COPD Symptoms Using NHANES 2007 – 2014 Datasets Among Women of Different Ethnic Backgrounds. Int J Nutr Food Sci. 2023;12(2):46-55. doi: 10.11648/j.ijnfs.20231202.12

    Copy | Download

  • @article{10.11648/j.ijnfs.20231202.12,
      author = {Kiano Manavi and Brenda Alston-Mills and Marvin Thompson and Ethan Davis and Jonathan Allen},
      title = {Effect of Smoking on Serum Vitamin D Levels and the Influence on COPD Symptoms Using NHANES 2007 – 2014 Datasets Among Women of Different Ethnic Backgrounds},
      journal = {International Journal of Nutrition and Food Sciences},
      volume = {12},
      number = {2},
      pages = {46-55},
      doi = {10.11648/j.ijnfs.20231202.12},
      url = {https://doi.org/10.11648/j.ijnfs.20231202.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijnfs.20231202.12},
      abstract = {Smoking is one of the major causes of chronic obstructive pulmonary disease (COPD). The number of women who smoke is increasing and they are at enhanced risk of developing fatal COPD. Symptoms of COPD include frequent coughing, wheezing, whistling, excess phlegm and shortness of breath. According to National Health Interview Survey (NHIS) data during 1999 to 2011, the prevalence of COPD among non-Hispanic whites was generally higher contrasted with non-Hispanic blacks and Hispanics. Among women the annual age-adjusted prevalence was higher than in men, especially among young women. It is likely that nutritional status of COPD patients may impact the outcome of the disease. Deficient levels of vitamin D is common among COPD patients. The goal of this study is to further investigate a potential correlation between smoking and serum vitamin D levels as it influences COPD. The National Health and Nutrition Examination Survey (NHANES) 2007-2014 datasets were utilized for this study. A 10 ng/mL decrease in vitamin D3 level was associated with an increased number of wheezing and whistling attacks (relative risk (RR) 1.33 (95% CI (1.03, 1.07), P=0.02). There was no evidence of an association between vitamin D2 with the number of wheezing and whistling attacks. Although there was no evidence of an association between vitamin D3 (either lower or higher levels) with bringing up phlegm and coughing, there was marginal evidence P2 with bringing up phlegm and coughing. Conclusion: This data confirmed the previous conclusion from an NHANES 2001-2006 investigation that smoking may still influence vitamin D3 levels among women. Further research is necessary to better understand whether vitamin D3 has a positive impact on respiratory health in women because they are more likely to be burdened by the symptoms of COPD.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Effect of Smoking on Serum Vitamin D Levels and the Influence on COPD Symptoms Using NHANES 2007 – 2014 Datasets Among Women of Different Ethnic Backgrounds
    AU  - Kiano Manavi
    AU  - Brenda Alston-Mills
    AU  - Marvin Thompson
    AU  - Ethan Davis
    AU  - Jonathan Allen
    Y1  - 2023/04/13
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ijnfs.20231202.12
    DO  - 10.11648/j.ijnfs.20231202.12
    T2  - International Journal of Nutrition and Food Sciences
    JF  - International Journal of Nutrition and Food Sciences
    JO  - International Journal of Nutrition and Food Sciences
    SP  - 46
    EP  - 55
    PB  - Science Publishing Group
    SN  - 2327-2716
    UR  - https://doi.org/10.11648/j.ijnfs.20231202.12
    AB  - Smoking is one of the major causes of chronic obstructive pulmonary disease (COPD). The number of women who smoke is increasing and they are at enhanced risk of developing fatal COPD. Symptoms of COPD include frequent coughing, wheezing, whistling, excess phlegm and shortness of breath. According to National Health Interview Survey (NHIS) data during 1999 to 2011, the prevalence of COPD among non-Hispanic whites was generally higher contrasted with non-Hispanic blacks and Hispanics. Among women the annual age-adjusted prevalence was higher than in men, especially among young women. It is likely that nutritional status of COPD patients may impact the outcome of the disease. Deficient levels of vitamin D is common among COPD patients. The goal of this study is to further investigate a potential correlation between smoking and serum vitamin D levels as it influences COPD. The National Health and Nutrition Examination Survey (NHANES) 2007-2014 datasets were utilized for this study. A 10 ng/mL decrease in vitamin D3 level was associated with an increased number of wheezing and whistling attacks (relative risk (RR) 1.33 (95% CI (1.03, 1.07), P=0.02). There was no evidence of an association between vitamin D2 with the number of wheezing and whistling attacks. Although there was no evidence of an association between vitamin D3 (either lower or higher levels) with bringing up phlegm and coughing, there was marginal evidence P2 with bringing up phlegm and coughing. Conclusion: This data confirmed the previous conclusion from an NHANES 2001-2006 investigation that smoking may still influence vitamin D3 levels among women. Further research is necessary to better understand whether vitamin D3 has a positive impact on respiratory health in women because they are more likely to be burdened by the symptoms of COPD.
    VL  - 12
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, USA

  • Department of Animal Science, North Carolina State University, Raleigh, USA

  • Department of Food Science and Human Nutrition, Michigan State University, East Lansing, USA

  • Department of Statistics, North Carolina State University, Raleigh, USA

  • Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, USA

  • Sections